204 related articles for article (PubMed ID: 7653738)
1. Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team.
Allergy; 1994 Sep; 49(8):611-5. PubMed ID: 7653738
[TBL] [Abstract][Full Text] [Related]
2. Topical levocabastine compared with orally administered terfenadine for the prophylaxis and treatment of seasonal rhinoconjunctivitis.
Søhoel P; Freng BA; Kramer J; Poppe S; Rebo R; Korsrud FR; Garud O; Woxen OJ; Olsen AK
J Allergy Clin Immunol; 1993 Jul; 92(1 Pt 1):73-81. PubMed ID: 8101534
[TBL] [Abstract][Full Text] [Related]
3. Topical levocabastine--an effective alternative to oral antihistamines in seasonal allergic rhinoconjunctivitis.
Bahmer FA
Clin Exp Allergy; 1995 Mar; 25(3):220-7. PubMed ID: 7788568
[No Abstract] [Full Text] [Related]
4. Safety and efficacy of topical levocabastine compared with oral terfenadine.
Bahmer FA; Ruprecht KW
Ann Allergy; 1994 May; 72(5):429-34. PubMed ID: 7909999
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
Vermeulen J; Mercer M
Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
[TBL] [Abstract][Full Text] [Related]
6. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
Noble S; McTavish D
Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ketotifen fumarate ophthalmic solution alone, desloratadine alone, and their combination for inhibition of the signs and symptoms of seasonal allergic rhinoconjunctivitis in the conjunctival allergen challenge model: a double-masked, placebo- and active-controlled trial.
Crampton HJ
Clin Ther; 2003 Jul; 25(7):1975-87. PubMed ID: 12946545
[TBL] [Abstract][Full Text] [Related]
8. Topical levocabastine, a selective H1 antagonist, in seasonal allergic rhinoconjunctivitis.
Bende M; Pipkorn U
Allergy; 1987 Oct; 42(7):512-5. PubMed ID: 2891316
[TBL] [Abstract][Full Text] [Related]
9. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
Janssens MM
Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
[TBL] [Abstract][Full Text] [Related]
10. A comparison of topical levocabastine and oral terfenadine in the treatment of allergic rhinoconjunctivitis. The Livostin Study Group.
Allergy; 1993 Oct; 48(7):530-4. PubMed ID: 7902024
[TBL] [Abstract][Full Text] [Related]
11. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups.
Berger WE; Fineman SM; Lieberman P; Miles RM
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):535-41. PubMed ID: 10400480
[TBL] [Abstract][Full Text] [Related]
12. Intranasal levocabastine for the treatment of seasonal allergic rhinitis: a multicentre, double-blind, placebo-controlled trial.
Dahl R; Pedersen B; Larsen B
Rhinology; 1995 Sep; 33(3):121-5. PubMed ID: 8560160
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.
Verin P; Easty DL; Secchi A; Ciprandi G; Partouche P; Nemeth-Wasmer G; Brancato R; Harrisberg CJ; Estivin-Ebrardt C; Coster DJ; Apel AJ; Coroneo MT; Knorr M; Carmichael TR; Kent-Smith BT; Abrantes P; Leonardi A; Cerqueti PM; Modorati G; Martinez M
Am J Ophthalmol; 2001 Jun; 131(6):691-8. PubMed ID: 11384563
[TBL] [Abstract][Full Text] [Related]
14. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
Janssens MM; Vanden Bussche G
Clin Exp Allergy; 1991 May; 21 Suppl 2():29-36. PubMed ID: 1680536
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of levocabastine nasal spray for seasonal allergic rhinitis.
Hampel FC; Martin BG; Dolen J; Travers S; Karcher K; Holton D
Am J Rhinol; 1999; 13(1):55-62. PubMed ID: 10088031
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
Falser N; Wober W; Rahlfs VW; Baehre M
Arzneimittelforschung; 2001; 51(5):387-93. PubMed ID: 11413739
[TBL] [Abstract][Full Text] [Related]
18. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis.
Frostad AB; Olsen AK
Clin Exp Allergy; 1993 May; 23(5):406-9. PubMed ID: 8101467
[TBL] [Abstract][Full Text] [Related]
19. Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe.
Kremer B; Tündermann A; Goldschmidt O
Arzneimittelforschung; 1998 Sep; 48(9):924-30. PubMed ID: 9793620
[TBL] [Abstract][Full Text] [Related]
20. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group.
Ratner PH; Lim JC; Georges GC
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1101-7. PubMed ID: 10856142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]